Your browser doesn't support javascript.
loading
Safety and efficacy of durvalumab in patients with head and neck squamous cell carcinoma: results from a phase I/II expansion cohort.
Segal, Neil H; Ou, Sai-Hong I; Balmanoukian, Ani; Fury, Matthew G; Massarelli, Erminia; Brahmer, Julie R; Weiss, Jared; Schöffski, Patrick; Antonia, Scott J; Massard, Christophe; Zandberg, Dan P; Khleif, Samir N; Xiao, Feng; Rebelatto, Marlon C; Steele, Keith E; Robbins, Paul B; Angra, Natasha; Song, Xuyang; Abdullah, Shaad; Butler, Marcus.
Afiliación
  • Segal NH; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA. Electronic address: segaln@mskcc.org.
  • Ou SI; Chao Family Comprehensive Cancer Center, Department of Medicine, Division of Hematology/Oncology, University of California School of Medicine, Orange, CA, USA.
  • Balmanoukian A; Hematology/Oncology, The Angeles Clinic and Research Institute, Los Angeles, CA, USA.
  • Fury MG; Department of Medicine, Head and Neck Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Massarelli E; Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Brahmer JR; Thoracic Oncology Program, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA.
  • Weiss J; Division of Hematology/Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
  • Schöffski P; Department of Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.
  • Antonia SJ; Department of Thoracic Oncology, Moffitt Cancer Center, Tampa, FL, USA.
  • Massard C; Université Paris Saclay, Université Paris-Sud, Drug Development Department, Gustave Roussy, Villejuif, France.
  • Zandberg DP; Head and Neck and Thyroid Cancer Disease Sections, University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, PA, USA.
  • Khleif SN; Georgia Cancer Center, Augusta University, Augusta, GA, USA.
  • Xiao F; Biostatistics, MedImmune, Gaithersburg, MD, USA.
  • Rebelatto MC; Translational Sciences, MedImmune, Gaithersburg, MD, USA.
  • Steele KE; Translational Sciences, MedImmune, Gaithersburg, MD, USA.
  • Robbins PB; Translational Sciences, MedImmune, Gaithersburg, MD, USA.
  • Angra N; Clinical Development, MedImmune, Gaithersburg, MD, USA.
  • Song X; Translational Sciences, MedImmune, Gaithersburg, MD, USA.
  • Abdullah S; Clinical Development, MedImmune, Gaithersburg, MD, USA.
  • Butler M; Tumor Immunotherapy Program, Princess Margaret Cancer Centre, Toronto, ON, Canada.
Eur J Cancer ; 109: 154-161, 2019 03.
Article en En | MEDLINE | ID: mdl-30731276
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antineoplásicos Inmunológicos / Carcinoma de Células Escamosas de Cabeza y Cuello / Neoplasias de Cabeza y Cuello / Anticuerpos Monoclonales Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Cancer Año: 2019 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antineoplásicos Inmunológicos / Carcinoma de Células Escamosas de Cabeza y Cuello / Neoplasias de Cabeza y Cuello / Anticuerpos Monoclonales Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Cancer Año: 2019 Tipo del documento: Article Pais de publicación: Reino Unido